Skip to main navigation Skip to search Skip to main content

A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder....

Project: Research

Project Details

StatusFinished
Effective start/end date12/27/1710/21/19

Funding

  • Janssen Research and Development LLC: $177,199.94